| Product Code: ETC9556655 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Sweden`s import market for hemostatic agents in 2024 was driven by shipments primarily from the Netherlands, Belgium, Czechia, Spain, and Germany. Despite the presence of multiple exporting countries, the market remained relatively unconcentrated with a low Herfindahl-Hirschman Index (HHI). The compound annual growth rate (CAGR) from 2020 to 2024 stood at 2.54%, indicating steady expansion. Notably, there was a notable growth spike in 2024 with a growth rate of 6.22%, showcasing increasing demand for hemostatic agents in the Swedish market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Hemostatic Agents Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Hemostatic Agents Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Hemostatic Agents Market - Industry Life Cycle |
3.4 Sweden Hemostatic Agents Market - Porter's Five Forces |
3.5 Sweden Hemostatic Agents Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Sweden Hemostatic Agents Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Sweden Hemostatic Agents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing number of surgeries and procedures requiring hemostatic agents |
4.2.2 Rising prevalence of chronic diseases leading to higher demand for hemostatic agents |
4.2.3 Technological advancements in hemostatic agents leading to improved efficacy and safety |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of hemostatic agents |
4.3.2 High cost associated with advanced hemostatic agents |
4.3.3 Limited awareness and adoption of hemostatic agents in certain healthcare settings |
5 Sweden Hemostatic Agents Market Trends |
6 Sweden Hemostatic Agents Market, By Types |
6.1 Sweden Hemostatic Agents Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Hemostatic Agents Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Sweden Hemostatic Agents Market Revenues & Volume, By Active Agents, 2021- 2031F |
6.1.4 Sweden Hemostatic Agents Market Revenues & Volume, By Passive Agents, 2021- 2031F |
6.1.5 Sweden Hemostatic Agents Market Revenues & Volume, By Combination, 2021- 2031F |
6.2 Sweden Hemostatic Agents Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Sweden Hemostatic Agents Market Revenues & Volume, By Large Hospital (500+ Beds), 2021- 2031F |
6.2.3 Sweden Hemostatic Agents Market Revenues & Volume, By Medium Hospital (250-499 Beds), 2021- 2031F |
6.2.4 Sweden Hemostatic Agents Market Revenues & Volume, By Small Hospitals (Less than 250 Beds), 2021- 2031F |
7 Sweden Hemostatic Agents Market Import-Export Trade Statistics |
7.1 Sweden Hemostatic Agents Market Export to Major Countries |
7.2 Sweden Hemostatic Agents Market Imports from Major Countries |
8 Sweden Hemostatic Agents Market Key Performance Indicators |
8.1 Number of surgical procedures performed annually in Sweden |
8.2 Adoption rate of advanced hemostatic agents in hospitals and clinics |
8.3 Research and development investment in new hemostatic agent technologies |
9 Sweden Hemostatic Agents Market - Opportunity Assessment |
9.1 Sweden Hemostatic Agents Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Sweden Hemostatic Agents Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Sweden Hemostatic Agents Market - Competitive Landscape |
10.1 Sweden Hemostatic Agents Market Revenue Share, By Companies, 2024 |
10.2 Sweden Hemostatic Agents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |